Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Delaloge

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?C Bailleux, L Lacroix, E Barranger, et al.
Journal De Radiologie|January 11, 2007
[Breast cancer screening: when the rear-guard places itself in the vanguard...]C Balleyguier, L Levy, B Boyer, et al.
British Journal of Cancer|November 19, 2009
Relation of risk of contralateral breast cancer to the interval since the first primary tumourC Rubino, R Arriagada, S Delaloge, et al.
European Journal of Cancer Care|December 28, 2016
New oral targeted therapies for metastatic breast cancer disrupt the traditional patients' management-A healthcare providers' viewE Martin, L Pourtau, M Di Palma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Safety of sentinel node biopsy in pregnant patientsG Dubernard, J R Garbay, R Rouzier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Pharmacokinetic interaction involving fenofibrate and everolimusO Mir, V Poinsignon, M Arnedos, et al.
Medical Oncology (Northwood, London, England)|January 23, 2014
Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?J Raphael, C Mazouni, O Caron, et al.
Bulletin Du Cancer|January 22, 1998
[Are there any arguments against hormone replacement therapy after treatment of ovarian adenocarcinoma?]C Lhommé, S Delaloge, E Gonçalves, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2004
Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implicationsP Morice, P Pautier, S Delaloge, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 4, 2010
Primary spindle rhabdomyosarcoma of the breast in an adult femaleA Rasinariu, F Andreiuolo, P Terrier, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?C Bailleux, L Lacroix, E Barranger, et al.
Journal De Radiologie|January 11, 2007
[Breast cancer screening: when the rear-guard places itself in the vanguard...]C Balleyguier, L Levy, B Boyer, et al.
British Journal of Cancer|November 19, 2009
Relation of risk of contralateral breast cancer to the interval since the first primary tumourC Rubino, R Arriagada, S Delaloge, et al.
European Journal of Cancer Care|December 28, 2016
New oral targeted therapies for metastatic breast cancer disrupt the traditional patients' management-A healthcare providers' viewE Martin, L Pourtau, M Di Palma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Safety of sentinel node biopsy in pregnant patientsG Dubernard, J R Garbay, R Rouzier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Pharmacokinetic interaction involving fenofibrate and everolimusO Mir, V Poinsignon, M Arnedos, et al.
Medical Oncology (Northwood, London, England)|January 23, 2014
Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?J Raphael, C Mazouni, O Caron, et al.
Bulletin Du Cancer|January 22, 1998
[Are there any arguments against hormone replacement therapy after treatment of ovarian adenocarcinoma?]C Lhommé, S Delaloge, E Gonçalves, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2004
Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implicationsP Morice, P Pautier, S Delaloge, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 4, 2010
Primary spindle rhabdomyosarcoma of the breast in an adult femaleA Rasinariu, F Andreiuolo, P Terrier, et al.
Pageof 11